
Blackstone and TPG Eye $17 Billion Hologic Acquisition
Blackstone and TPG are in advanced talks to acquire medical device maker Hologic for over $17 billion, potentially becoming one of 2025's largest private equity deals.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Blackstone and TPG are in advanced talks to acquire medical device maker Hologic for over $17 billion, potentially becoming one of 2025's largest private equity deals.
Mubadala Capital explores acquisition of Clear Channel Outdoor Holdings as outdoor advertising deals heat up globally. Stock jumps 19% on takeover speculation.
Jefferies and Wedbush maintain Buy ratings on Viridian Therapeutics as Roche's thyroid eye disease drug shows weaker results than Viridian's veligrotug therapy.
Jefferies raises Atai Life Sciences price target to $10 following FDA Breakthrough Therapy Designation for depression drug BPL-003, citing 72% approval rate for BTD drugs.
The White House will extend tariff relief for US carmakers by five years, helping Ford, GM, and others reduce costs from Trump's import duties on auto parts and vehicles.
Chiesi and Protalix received a negative CHMP opinion for Elfabrio's dosing regimen. The companies remain committed to reducing the treatment burden for Fabry disease patients.